KRT18 and breast neoplasm: K18 may play a regulatory role in hormonally responsive breast cancer, as it can associate with and sequester the ERα target gene and ERα coactivator LRP16 in the cytoplasm, thus attenuating ERα-mediated signaling and estrogen-stimulated cell cycle progression in breast tumor cells [53].